Navigation Links
2 studies find new genetic links to ovarian cancer risk
Date:9/19/2010

nd BRCA2, researchers conclude that they probably cause a much greater proportion of all ovarian cancers, even though the overall cancer risks associated with these SNPs are smaller.

Simon Gayther, PhD, Professor of Preventive Medicine at the University of Southern California and senior author of the second ovarian cancer study, said: "Our study shows that the same genetic region plays a role in both breast and ovarian cancer, suggesting that the same faulty pathway can cause both diseases, just like BRCA1 and BRCA2 do. This is important because it suggests that women who carry certain versions of this stretch of DNA could benefit from closer monitoring for both breast and ovarian cancers."

Paul Pharoah, PhD, of Cancer Research UK Center for Genetic Epidemiology at Cambridge University and a senior author on both studies, says, "I think that the most important message women can take away from this work is that we are making progress in understanding ovarian cancer."

"We are slowly but clearly leading toward a time when we will be able to draw an individualized profile of a woman's risk of ovarian cancer and respond with appropriate prevention and treatment options."

The findings may represent the tip of the iceberg, according to Georgia Chenevix-Trench, PhD, from the Queensland Institute of Medical Research in Australia, who led development of a consortium dedicated to studying the outcomes associated with BRCA1 and BRCA2 mutations. She said future research may yield additional genetic regions that alter a woman's risk of ovarian and other cancers.


'/>"/>

Contact: Michelle Gailiun
michelle.gailiun@duke.edu
919-724-5343
Duke University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Studies on combat-related substance use and abuse to be funded by NIH and VA
2. Biomarkers Could Spot Alzheimers Disease Early, Studies Suggest
3. Studies offer encouraging data on preventing Crohns disease recurrence
4. Genome Studies Point to Cholesterol-Regulating Genes
5. New studies question vascular multiple sclerosis hypothesis and treatment
6. Snake venom studies yield insights for development of therapies for heart disease and cancer
7. CIHR team grant to fund multidisciplinary breast cancer survivorship studies
8. FDA accepts historical controls for epilepsy monotherapy studies
9. Studies explore effects of war on former child soldiers
10. Pediatric clinical studies appear prone to bias, Hopkins review shows
11. Studies of womens attitudes to social egg freezing find reasons differ with age
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... June 03, 2015 AvePoint, ... and devices, announced today that it has won the ... and Content. The company was honored among a global ... in innovation and implementation of customer solutions based on ... of the Year Awards – including the 2014 Microsoft ...
(Date:6/3/2015)... Follow us on LinkedIn ... disease treatment on account of their better mode of ... as rheumatoid arthritis. The industry is expected to witness ... molecule drugs to biopharmaceuticals over the coming years. The ... gene therapies, and recombinant proteins has attracted industry players ...
(Date:6/3/2015)... Newark, New Jersey (PRWEB) June 03, 2015 ... chosen by Diversity MBA Magazine as one of the nation’s ... ranked Horizon BCBSNJ No. 6 among its national list of ... ranked Horizon BNCBSNJ as the No. 1 Regional Company. ... been honored by Diversity MBA Magazine for its diverse workplace ...
(Date:6/3/2015)... 03, 2015 Justina Molzon, MS Pharm, ... at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award ... level of excellence, and commitment to service on a ... Excellence in Service Award that recognizes the “Member of ... DIA volunteer and who has contributed to the advancement ...
(Date:6/3/2015)... Researchers at the University of Western Australia ... the tried-and-true marker mesothelin is the best option available. ... research. Click here to read it now. ... Related Diseases say, even though a mesothelin test can ... to fibulin-3 for identifying mesothelioma. , “Preliminary results ...
Breaking Medicine News(10 mins):Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 2Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2
... , FRIDAY, Nov. 9 (HealthDay News) -- A drug called ... patients with chronic active gout. , That,s according to a ... who had gout for an average of 13 years. , ... VA Medical Center and University of California, San Diego. , ...
... robots.,It sounds like the theme of a cartoon ... and innovative research being conducted at the University ... cognitive,development of infants with special needs., Two ... professor of,physical therapy, and Sunil Agrawal, professor of ...
... Nov. 9 World Diabetes Day is,November 14, ... celebrating the,successful launch of the 12-Day Stopping Diabetes ... treatments for type 2 diabetes, this,program focuses on ... its patients. Dr. Stuart Seale, medical director ...
... Washington, DC November 9, 2007 Shire plc ... biopharmaceutical company, yesterday announced results of a national survey ... to12 year old childs once-daily Attention Deficit Hyperactivity Disorder ... survey findings report the perceptions of 500 parents of ...
... DAKAR, Senegal -- The National Academy of Sciences and ... of the African Science Academy Development Initiative (ASADI), a ... to provide their nations with evidence-based advice. The ... the value of this advice in informing decisions about ...
... Bulletin Board:,NTRZ), a health science company and a ... that it will release its third quarter financial,results ... Management will host the conference call on ... 2007 third quarter financial results and provide,management updates. ...
Cached Medicine News:Health News:Babies Driving Robots at University 2Health News:Babies Driving Robots at University 3Health News:Babies Driving Robots at University 4Health News:Babies Driving Robots at University 5Health News:Babies Driving Robots at University 6Health News:New Sedona Stopping Diabetes Program 2Health News:Parents survey: Perceptions of the duration of their child's ADHD medication 2Health News:Safe water is theme of African science academies conference in Senegal 2Health News:NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14 2
(Date:6/3/2015)... NEW YORK , June 3, 2015 ... grow at a CAGR of 10.1% from 2014 to ... market is driven by factors, such as the rising ... and growing technology advancements. However, factors such as lack ... the growth of this market. In ...
(Date:6/3/2015)... 3, 2015  Diomics today announced that Stephen ... has joined the company,s board of directors, effective immediately. ... Project and Clinical Professor at the Lyndon B. Johnson ... at Austin. "Steve brings an incredible ... years as a member of CIA,s clandestine service, including ...
(Date:6/3/2015)... DUBLIN , June 3, 2015  Actavis plc (NYSE: ... that Brent Saunders , CEO and President of Actavis, ... at the Goldman Sachs 36th Annual Global Healthcare Conference in ... Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO The presentation ... a.m. Pacific Time at the Terranea Resort, Rancho ...
Breaking Medicine Technology:Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 2Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 3Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference 2
... Serina Therapeutics, Inc. President and CEO Randall Moreadith, MD, PhD, ... financing round to advance its lead oncology candidate SER-203 into ... "We are pleased to report to our existing and ... launched in late 2010. This is a very significant milestone ...
... (Nasdaq: ENDP ) today announced that Alan Levin, ... corporate overview at the Goldman Sachs Global Healthcare Conference on ... will be held at the Terranea Resort in Rancho Palos ... of the presentation will be available on the company,s website ...
Cached Medicine Technology:Serina Therapeutics, Inc. Closes $9.5 Million Financing Round 2
... Prep Pads prepares the skin for improved ... dry, it leaves a thin film on ... surface and a barrier for natural body ... a dressing or tape. Skin Protectant is ...
... 70% USP and 10% Acetone Alcohol Prep ... antiseptic, anti-infective prior to administering injections. Acetone ... and fats from the skin. They are ... to contain a consistent amount of alcohol ...
Triad Plus Sterile Isopropyl Alcohol 70% USP Prep Pads are medium size. Each package is terminally sterilized, ensuring the safest possible product....
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
Medicine Products: